List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million) Introduction
1.2 Global Biotherapeutics Cell Line Development Outlook 2017 VS 2022 VS 2028
1.2.1 Global Biotherapeutics Cell Line Development Market Size for the Year 2017-2028
1.2.2 Global Biotherapeutics Cell Line Development Market Size for the Year 2017-2028
1.3 Biotherapeutics Cell Line Development Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Biotherapeutics Cell Line Development in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Biotherapeutics Cell Line Development Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Biotherapeutics Cell Line Development Market Dynamics
1.4.1 Biotherapeutics Cell Line Development Industry Trends
1.4.2 Biotherapeutics Cell Line Development Market Drivers
1.4.3 Biotherapeutics Cell Line Development Market Challenges
1.4.4 Biotherapeutics Cell Line Development Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Biotherapeutics Cell Line Development by Type
2.1 Biotherapeutics Cell Line Development Market Segment by Type
2.1.1 Transfection & Selection
2.1.2 Single Cell Cloning
2.2 Global Biotherapeutics Cell Line Development Market Size by Type (2017, 2022 & 2028)
2.3 Global Biotherapeutics Cell Line Development Market Size by Type (2017-2028)
2.4 United States Biotherapeutics Cell Line Development Market Size by Type (2017, 2022 & 2028)
2.5 United States Biotherapeutics Cell Line Development Market Size by Type (2017-2028)
3 Biotherapeutics Cell Line Development by Application
3.1 Biotherapeutics Cell Line Development Market Segment by Application
3.1.1 In-house
3.1.2 Outsource
3.1.3 Hybrid
3.1.4 Do-It-Yourself (DIY)
3.2 Global Biotherapeutics Cell Line Development Market Size by Application (2017, 2022 & 2028)
3.3 Global Biotherapeutics Cell Line Development Market Size by Application (2017-2028)
3.4 United States Biotherapeutics Cell Line Development Market Size by Application (2017, 2022 & 2028)
3.5 United States Biotherapeutics Cell Line Development Market Size by Application (2017-2028)
4 Global Biotherapeutics Cell Line Development Competitor Landscape by Company
4.1 Global Biotherapeutics Cell Line Development Market Size by Company
4.1.1 Top Global Biotherapeutics Cell Line Development Companies Ranked by Revenue (2021)
4.1.2 Global Biotherapeutics Cell Line Development Revenue by Player (2017-2022)
4.2 Global Biotherapeutics Cell Line Development Concentration Ratio (CR)
4.2.1 Biotherapeutics Cell Line Development Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biotherapeutics Cell Line Development in 2021
4.2.3 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Biotherapeutics Cell Line Development Headquarters, Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million) Type
4.3.1 Global Biotherapeutics Cell Line Development Headquarters and Area Served
4.3.2 Global Biotherapeutics Cell Line Development Companies Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Biotherapeutics Cell Line Development Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Biotherapeutics Cell Line Development Market Size by Company
4.5.1 Top Biotherapeutics Cell Line Development Players in United States, Ranked by Revenue (2021)
4.5.2 United States Biotherapeutics Cell Line Development Revenue by Players (2020, 2021 & 2022)
5 Global Biotherapeutics Cell Line Development Market Size by Region
5.1 Global Biotherapeutics Cell Line Development Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Biotherapeutics Cell Line Development Market Size by Region (2017-2028)
5.2.1 Global Biotherapeutics Cell Line Development Market Size by Region: 2017-2022
5.2.2 Global Biotherapeutics Cell Line Development Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.1.2 North America Biotherapeutics Cell Line Development Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Biotherapeutics Cell Line Development Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.3.2 Europe Biotherapeutics Cell Line Development Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.4.2 Latin America Biotherapeutics Cell Line Development Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Biotherapeutics Cell Line Development Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Becton Dickinson & Company
7.1.1 Becton Dickinson & Company Company Details
7.1.2 Becton Dickinson & Company Business Overview
7.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Introduction
7.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.1.5 Becton Dickinson & Company Recent Development
7.2 Beckman Coulter
7.2.1 Beckman Coulter Company Details
7.2.2 Beckman Coulter Business Overview
7.2.3 Beckman Coulter Biotherapeutics Cell Line Development Introduction
7.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.2.5 Beckman Coulter Recent Development
7.3 Boehringer Ingelheim Group
7.3.1 Boehringer Ingelheim Group Company Details
7.3.2 Boehringer Ingelheim Group Business Overview
7.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Introduction
7.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.3.5 Boehringer Ingelheim Group Recent Development
7.4 Catalent Inc.
7.4.1 Catalent Inc. Company Details
7.4.2 Catalent Inc. Business Overview
7.4.3 Catalent Inc. Biotherapeutics Cell Line Development Introduction
7.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.4.5 Catalent Inc. Recent Development
7.5 CMC Biologics A/S
7.5.1 CMC Biologics A/S Company Details
7.5.2 CMC Biologics A/S Business Overview
7.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Introduction
7.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.5.5 CMC Biologics A/S Recent Development
7.6 Lonza Group Ltd.
7.6.1 Lonza Group Ltd. Company Details
7.6.2 Lonza Group Ltd. Business Overview
7.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Introduction
7.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.6.5 Lonza Group Ltd. Recent Development
7.7 EMD Millipore
7.7.1 EMD Millipore Company Details
7.7.2 EMD Millipore Business Overview
7.7.3 EMD Millipore Biotherapeutics Cell Line Development Introduction
7.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.7.5 EMD Millipore Recent Development
7.8 Partec (Sysmex Corporation)
7.8.1 Partec (Sysmex Corporation) Company Details
7.8.2 Partec (Sysmex Corporation) Business Overview
7.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Introduction
7.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.8.5 Partec (Sysmex Corporation) Recent Development
7.9 ProBioGen AG
7.9.1 ProBioGen AG Company Details
7.9.2 ProBioGen AG Business Overview
7.9.3 ProBioGen AG Biotherapeutics Cell Line Development Introduction
7.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.9.5 ProBioGen AG Recent Development
7.10 Selexis SA
7.10.1 Selexis SA Company Details
7.10.2 Selexis SA Business Overview
7.10.3 Selexis SA Biotherapeutics Cell Line Development Introduction
7.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.10.5 Selexis SA Recent Development
7.11 Sigma-Aldrich Co. LLC.
7.11.1 Sigma-Aldrich Co. LLC. Company Details
7.11.2 Sigma-Aldrich Co. LLC. Business Overview
7.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Introduction
7.11.4 Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.11.5 Sigma-Aldrich Co. LLC. Recent Development
7.12 Sony Biotechnology Inc.
7.12.1 Sony Biotechnology Inc. Company Details
7.12.2 Sony Biotechnology Inc. Business Overview
7.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Introduction
7.12.4 Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.12.5 Sony Biotechnology Inc. Recent Development
7.13 Thermo Fisher Scientific Inc.
7.13.1 Thermo Fisher Scientific Inc. Company Details
7.13.2 Thermo Fisher Scientific Inc. Business Overview
7.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Introduction
7.13.4 Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.13.5 Thermo Fisher Scientific Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
